Paul Tudor Jones Pep Gen Inc. Transaction History

Tudor Investment Corp Et Al

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$11.44 - $17.7 $1.08 Million - $1.67 Million	-94,276 Reduced 73.78%	33,508 $410,000
Q4 2022 Feb 14, 2023	SELL	$9.31 - $16.57 $863,465 - $1.54 Million	-92,746 Reduced 42.06%	127,784 $1.71 Million
Q3 2022 Nov 14, 2022	SELL	$4.86 - $12.75 $341,939 - $897,064	-70,358 Reduced 24.19%	220,530 $1.57 Million
Q2 2022 Aug 15, 2022	BUY	$9.0 - $12.89 $2.62 Million - $3.75 Million	290,888 New	290,888 $2.51 Million

24.7M

15K

Ticker PEPG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,631,900
Market Cap $57.4M
Description
PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is a...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.